E3040
A member of the class of benzothiazoles that is 1,3-benzothiazole substituted by a methylnitrilo group, (pyridin-3-yl)methyl group, methyl group, hydroxy group and methyl group at position 2,4,5,6 and 7, respectively. It is a dual inhibitor of 5-lipoxygenase and thromboxane A2 synthetase and exhibits anti-inflammatory properties. The drug was being developed by Eisai (Tokyo, Japan) for the treatment of bowel disease. — ChEBI
Quick answers about E3040
Identity · formula · massWhat is E3040, CAS 145096-30-6?
E3040 is the substance linked to CAS 145096-30-6 in ChEBI entry CHEBI:4732. The reported formula is C16H17N3OS. Confirm the structural identifiers when distinguishing salts, hydrates, isomers or isotopically labelled materials.
Source ↗What is the molar mass of E3040?
The ChEBI-reported molar mass is 299.399 g/mol for formula C16H17N3OS. Its source-reported monoisotopic mass is 299.10923 Da; that uses a specific isotope composition and is a different quantity.
Source ↗Which PubChem properties are available for E3040?
CID 443292 is connected to this record by an exact InChIKey match. PubChem reports exact mass 299.10923335 Da. computed XLogP 3.9. Values and source conventions are shown separately in the property tables below.
Source ↗Identity & molecular properties
Source-linked values| CAS number | 145096-30-6 | ChEBI ↗ |
| Chemical formula | C16H17N3OS | ChEBI ↗ |
| Molar mass | 299.399 g/mol | ChEBI ↗ |
| Monoisotopic mass | 299.10923 Da | ChEBI ↗ |
| Formal charge | 0 | ChEBI ↗ |
| ChEBI identifier | CHEBI:4732 | ChEBI ↗ |
PubChem molecular properties
PubChem| Molar mass | 299.4 g/mol | PubChem ↗ |
| Exact mass | 299.10923335 Da | PubChem ↗ |
| Computed XLogP | 3.9 | PubChem ↗ |
| Topological polar surface area (Ų) | 86.3 | PubChem ↗ |
| H-bond donors | 2 | PubChem ↗ |
| H-bond acceptors | 5 | PubChem ↗ |
| Rotatable bonds | 3 | PubChem ↗ |
PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.
Names & structural identifiers
Copy any identifierE30405,7-dimethyl-2-(methylamino)-4-(pyridin-3-ylmethyl)-1,3-benzothiazol-6-olIONAQTGMWFXHIX-UHFFFAOYSA-NCNc1nc2c(Cc3cccnc3)c(C)c(O)c(C)c2s1InChI=1S/C16H17N3OS/c1-9-12(7-11-5-4-6-18-8-11)13-15(10(2)14(9)20)21-16(17-3)19-13/h4-6,8,20H,7H2,1-3H3,(H,17,19)Names & synonyms
Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.
Classification & relationships
ChEBI ontologyRoles recorded in ChEBI
Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.
Safety documents & references
Supplier matching mattersFind the safety document for your specific supplier, product number and grade.
Find a product-specific SDS
Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.
Mass ↔ amount of substance
Calculated from sourced massUses 299.399 g/mol from ChEBI; basis: the substance and formula represented in this record. No purity or concentration correction is applied.
Elemental composition
Theoretical mass fractionsCNSHOCalculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.
Research & patent references
Selected source associationsSources & record history
Checked 27 Sep 2026Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0
PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.